Corbus Pharmaceuticals Holdings (CRBP) Free Cash Flow Growth (3y) (2016 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Free Cash Flow Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 24.91% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 20.11% |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 14.71% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 135.08 Mn | 107.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -28.99% |
| Jun 30, 2025 | -10.72% |
| Mar 31, 2025 | -15.60% |
| Dec 31, 2024 | -3.90% |
| Sep 30, 2024 | -163.37% |
| Jun 30, 2024 | 20.09% |
| Mar 31, 2024 | 28.51% |
| Dec 31, 2023 | 30.85% |
| Sep 30, 2023 | 35.95% |
| Jun 30, 2023 | 33.58% |
| Mar 31, 2023 | 18.64% |
| Dec 31, 2022 | 32.14% |
| Sep 30, 2022 | 26.55% |
| Jun 30, 2022 | 9.64% |
| Mar 31, 2022 | -44.82% |
| Dec 31, 2021 | 11.28% |
| Sep 30, 2021 | 27.98% |
| Jun 30, 2021 | -59.47% |
| Mar 31, 2021 | -96.62% |
| Dec 31, 2020 | -23.30% |